Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Mol Cancer. 2023 Jul 29;22(1):120. doi: 10.1186/s12943-023-01829-4.
Mol Cancer. 2023.
PMID: 37516818
Free PMC article.
Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?
Niogret J, Dalens L, Truntzer C, Chevrier S, Favier L, Lagrange A, Coudert B, Fraisse C, Foucher P, Zouak A, Westeel V, Goussot V, Dérangère V, Albuisson J, Arnould L, Boidot R, Kaderbhai CG, Ghiringhelli F.
Niogret J, et al. Among authors: dalens l.
Lung Cancer. 2021 Nov;161:98-107. doi: 10.1016/j.lungcan.2021.08.013. Epub 2021 Aug 29.
Lung Cancer. 2021.
PMID: 34560426
Item in Clipboard
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life.
Dalens L, Niogret J, Kaderbhai CG, Boidot R.
Dalens L, et al.
Front Oncol. 2022 Mar 7;12:863057. doi: 10.3389/fonc.2022.863057. eCollection 2022.
Front Oncol. 2022.
PMID: 35330711
Free PMC article.
Item in Clipboard
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
Dalens L, Lecuelle J, Favier L, Fraisse C, Lagrange A, Kaderbhai C, Boidot R, Chevrier S, Mananet H, Derangère V, Truntzer C, Ghiringhelli F.
Dalens L, et al.
Int J Mol Sci. 2023 Apr 20;24(8):7592. doi: 10.3390/ijms24087592.
Int J Mol Sci. 2023.
PMID: 37108755
Free PMC article.
Item in Clipboard
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report.
Roussot N, Lecuelle J, Dalens L, Truntzer C, Ghiringhelli F.
Roussot N, et al. Among authors: dalens l.
J Immunother Cancer. 2023 Oct;11(10):e007763. doi: 10.1136/jitc-2023-007763.
J Immunother Cancer. 2023.
PMID: 37890888
Free PMC article.
Item in Clipboard
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Roussot N, Fumet JD, Limagne E, Thibaudin M, Hervieu A, Hennequin A, Zanetta S, Dalens L, Fourrier T, Galland L, Jacob P, Bertaut A, Rederstorff E, Chevalier C, Ghirardi S, Gilbert E, Khoukaz A, Martin E, Nicolet C, Quivrin M, Thibouw D, Vulquin N, Truc G, Rouffiac M, Ghiringhelli F, Mirjolet C.
Roussot N, et al. Among authors: dalens l.
BMC Cancer. 2023 Nov 9;23(1):1080. doi: 10.1186/s12885-023-11534-6.
BMC Cancer. 2023.
PMID: 37946136
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite